Cardiologia
Seguimento de longo prazo de estudo randomizado | Efeitos da metformina por longo prazo e de intervenções no estilo de vida sobre eventos cardiovasculares no Diabetes Prevention Program and Its Outcome Study (DPPOS).
25 Mai, 2022 | 13:47hComunicado de imprensa: Lifestyle changes, meds effective to prevent or delay Type 2 diabetes; no change in CVD – American Heart Association
Análise de especialista | Toxicidades vasculares de novas terapias oncológicas.
25 Mai, 2022 | 13:26hVascular Toxicities of Novel Cancer Therapies – American College of Cardiology
Revisão | Classes atuais e emergentes de agentes farmacológicos para tratamento de hipertensão.
25 Mai, 2022 | 13:24hCurrent and Emerging Classes of Pharmacological Agents for the Management of Hypertension – American Journal of Cardiovascular Drugs (se o acesso a este link for pago, tente este)
Suporte circulatório mecânico: revisão para nefrologistas.
25 Mai, 2022 | 13:19hConteúdos relacionados:
Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art – Critical Care
M-A | Efeito dos inibidores do cotransportador 2 de sódio e glicose sobre a insuficiência cardíaca com fração de ejeção preservada.
25 Mai, 2022 | 13:16hConsenso de especialistas | Tratamento de lesões de bifurcação coronariana.
24 Mai, 2022 | 11:42h
Comentário no Twitter
Coinciding with the beginning of #EuroPCR, the 16th Expert Consensus Document of the European Bifurcation Club is online ahead of print with two publications: Part 1 on the provisional pathway and Part 2 on two-stent strategies. https://t.co/cfECcOi0GJhttps://t.co/gjUrYKV2qK pic.twitter.com/IlX8GhKLQU
— Davide Capodanno (@DFCapodanno) May 15, 2022
Estudo de coorte | Associação entre intensidade do tratamento com hormônio da tireoide e mortalidade cardiovascular.
24 Mai, 2022 | 11:35hComentários:
Thyroid Hormone Treatment Intensity and Cardiovascular Mortality – American College of Cardiology
Thyroid Hormone Treatment Intensity May Be Modifiable Risk Factor for CV Mortality – HCP Live
Comentário no Twitter
In this cohort study of US Veterans on thyroid hormone therapy, both exogenous hyperthyroidism and hypothyroidism contributed to the increased risk of cardiovascular mortality after adjusting for demographic and traditional cardiovascular risk factors. https://t.co/NO4776Ia4m
— JAMA Network Open (@JAMANetworkOpen) May 12, 2022
Microfragmentação QRS como preditor de mortalidade.
24 Mai, 2022 | 11:32hQRS micro-fragmentation as a mortality predictor – European Heart Journal
Editorial: The fractionated QRS complex for cardiovascular risk assessment – European Heart Journal
Comentário no Twitter
QRS micro-fragmentation as a mortality predictor: discover more in EHJ! https://t.co/P0gkPFpIs8#EKG #QRS #fragmentation #prediction #outcome #cardiotwitter @escardio @ESC_Journals pic.twitter.com/8IAIL3fXFF
— EHJ Editor-in-Chief (@ehj_ed) February 22, 2022
Sob licença de https://creativecommons.org/licenses/by/4.0/
Definições e desfechos padronizados para tratamento de bifurcações coronarianas.
24 Mai, 2022 | 11:31hDefinitions and Standardized Endpoints for Treatment of Coronary Bifurcations – EuroIntervention
Comentário no Twitter
There is a paucity of standardization and comparability across studies involving coronary bifurcation lesions. The BIF-ARC document (first joint publication of @EuroInterventio and @JACCJournals) provides definitions and criteria for use in such studies.https://t.co/HyCHitD2CI pic.twitter.com/uSn2eSTMyo
— Davide Capodanno (@DFCapodanno) May 18, 2022
Revisão | Asma alérgica é um fator de risco para doenças cardiovasculares.
24 Mai, 2022 | 11:26hAllergic asthma is a risk factor for human cardiovascular diseases – Nature Cardiovascular Research
Comentário no Twitter
A Review in @NatureCVR discusses how asthma and allied allergic conditions may contribute to the prevalence, incidence and progression of cardiovascular diseases and vice versa. https://t.co/6kRj9LvOfa pic.twitter.com/Ydq8X2k1rY
— Nature Portfolio (@NaturePortfolio) May 18, 2022